98%
921
2 minutes
20
Objective: To investigate the effects of cardiopulmonary bypass (CPB) on plasma pentraxin-3 (PTX3) level and balance of Th1/Th2 function in children with congenital heart malformations.
Methods: 16 children with congenital heart malformations, 9 male and 7 female, aged 3 - 52 months, weighing 3.4 - 14.5 kilograms, classified as II or III ASA grades, underwent operation under CPB. Blood samples were collected after anesthesia induction, 5 min and 30 min since beginning of CPB, and 5 min, 2 h, 4 h, 8 h, and 16 h after weaning from CPB. ELISA was used to examine the plasma concentrations of interferon (INF)-gamma, interleukin (IL)-4, and PTX3. The ratio of INF-gamma/IL-4 was calculated.
Results: The INF-gamma level began to increase significantly 5 min since CPB (P < 0.05), peaked 5 min after weaning from CPB (P < 0.01), then gradually decreased, and returned to the level before CPB 16 h after the weaning from CPB (P > 0.05). The IL-4 level began to increase significantly 30 min since CPB (P < 0.01), peaked 2 h since CPB (P < 0.01), however, still not returned to the level before CPB 16 h after the weaning from CPB (P < 0.05). The PTX-3 level was significantly higher 30 min since CPB and 5 min and 2 h after the weaning from CPB (all P < 0.01). The INF-gamma/IL-4 ratio was significantly higher 5 min and 30 min since CPB and 5 min after weaning from CPB (all P > 0.05).
Conclusion: CPB can leads to elevation of plasma concentration of PTX3 and drift of Th1/Th2 function equilibrium, thus resulting in immunity disequilibrium.
Download full-text PDF |
Source |
---|
Clin Transplant
September 2025
Cedars-Sinai Smidt Heart Institute, Los Angeles, California, USA.
Background: Severe left ventricular/biventricular primary graft dysfunction (PGD-LV) continues to be a major contributor to 30-day mortality post-heart transplantation (HTx). In patients with severe PGD-LV, two distinctive presentation phenotypes are encountered: an "immediate PGD" (IP), where patients fail to wean from cardiopulmonary bypass (CPB), or a "delayed PGD" (DP) following successful weaning from CPB and/or transfer from the operating room. Data on these phenotypes' incidence, associated characteristics, and outcomes remain limited.
View Article and Find Full Text PDFWorld J Clin Cases
August 2025
Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Background: In open heart surgery requiring cardiopulmonary bypass (CPB), ventricular fibrillation (VF) is common, but refractory recurrent VF is uncommon but perilous.
Case Summary: This article reports a 58-year-old male patient with an ascending aortic aneurysm who presented for a Bentall procedure and subsequently experienced multiple occurrences of unexplained VF after weaning from CPB. The recurrent episodes of VF in this case were felt to be related to coronary insufficiency after reconstruction of the aortic root.
Perfusion
August 2025
Public Health, Caritas Hospital & Institute of Health Sciences, Kottayam, India.
BackgroundTraditional cardioplegia strategies often fail in cases with patent coronary grafts due to continuous myocardial perfusion, this necessitates for alternate approaches such as systemic hyperkalemic cardiac arrest. During redo cardiac surgeries, a patent left internal mammary artery (LIMA) might prevent the heart from maintaining electrical cardiac arrest. Induced systemic hyperkalaemia is a novel approach to maintain cardiac electromechanical arrest.
View Article and Find Full Text PDFCureus
July 2025
Department of Anaesthesiology, Seirei Hamamatsu General Hospital, Hamamatsu, JPN.
Coagulation management poses a challenge for post-Fontan patients requiring anesthesia for aortic valve replacement (AVR). This is because post-Fontan patients have a history of multiple sternotomies and resultant strong adhesions, in addition to being potentially deficient in coagulation factors, as observed in several post-Fontan patients. Moreover, coagulation factors are further diluted and consumed during cardiopulmonary bypass (CPB).
View Article and Find Full Text PDFInterdiscip Cardiovasc Thorac Surg
September 2025
Department of Cardiopulmonary Bypass, National Center for Cardiovascular Diseases & Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, 10037 Beijing, China.
Objectives: Deep hypothermic circulatory arrest (DHCA) is known to trigger a systemic inflammatory response and ischaemia-reperfusion injury, leading to exacerbated lung dysfunction. Ulinastatin (UTI) is a commonly used anti-inflammatory drug in clinical settings, but its protective effects may vary depending on the timing and dosage.
Methods: A rat model of DHCA was established, and 2 different doses of UTI (5/10 × 104 U/kg; low/high dose) were administered.